Try our Advanced Search for more refined results
Health
-
April 10, 2026
Taxation With Representation: Goodwin, CMS, Wilson Sonsini
In this week's Taxation With Representation, Gilead Sciences Inc. acquires clinical-stage biotechnology company Tubulis GmbH, private equity firm Court Square Capital Partners closes a multibillion-dollar fund and Neurocrine Biosciences Inc. buys rare-disease drugmaker Soleno Therapeutics Inc.
-
April 10, 2026
Ill. Jury Adds $17M Punitive Award To Baby Formula Verdict
Illinois jurors on Friday slapped another $17 million in punitive damages atop the $53 million they awarded the previous afternoon to four mothers who accused Abbott Laboratories of selling preterm infant formula that contributed to a serious and often fatal gut condition their babies developed.
-
April 10, 2026
UK Litigation Roundup: Here's What You Missed In London
The past week in London has seen the owner of an oil tanker stuck in the Strait of Hormuz sued by an energy company and an insurer, law firm Boodle Hatfield LLP and two Serle Court barristers sued by a group of Winston Churchill's great-grandchildren, and Welsh Water hit with a fresh class action over polluted rivers.
-
April 10, 2026
US Outpaces Global M&A Amid 'Made In America' Push
U.S. companies were a major driver of a global M&A rebound in the first quarter of 2026, with domestic dealmaking surging to its strongest start in four years and outpacing global growth amid lower borrowing costs and a "Made in America" policy push, according to a first-quarter Mergermarket report.
-
April 09, 2026
Yale Medical School Can't Nix Fraudulent Insemination Suit
Yale can't escape a negligence suit by onetime patients alleging its former fertility doctor secretly inseminated them with his own sperm, after a Connecticut judge said that a letter from an anonymous doctor, which is mandated by law to support their claims, met the statutory requirements.
-
April 09, 2026
Swiss Firm Says Clause Required Zurich Hospital Arbitration
A D.C. federal judge is being called upon to again enforce a roughly $8.6 million arbitral award issued against Equatorial Guinea in a dispute over an ill-fated hospital operating contract, months after his initial enforcement ruling was overturned by the D.C. Circuit.
-
April 09, 2026
Clinic Charged Patients For Faulty Mammograms, Suit Claims
A West Virginia clinic provided "worthless" mammograms to hundreds of patients for more than two years, according to a proposed class action filed in federal court which seeks refunds and other damages in excess of $5 million.
-
April 09, 2026
Irish Mallinckrodt Unit Stuck In Drug Price-Fixing Suit
An Irish entity of drugmaker Mallinckrodt waited too long to seek dismissal of a price-fixing lawsuit brought by states based on a lack of personal jurisdiction or proper service, a Connecticut federal judge has ruled, finding that the company first raised that argument more than five years after the complaint was filed.
-
April 09, 2026
Cigna 401(k) Suit Won't Wait For Intel Supreme Court Decision
A Pennsylvania federal court turned down Cigna's bid to stay a proposed class action alleging the insurance company misspent forfeitures from its employee 401(k) plan and offered an underperforming investment fund while the U.S. Supreme Court considers a 401(k) suit against Intel, finding the request unjustified.
-
April 09, 2026
Abbott Hit With $53M Verdict Over Baby Formula Harms
A Cook County jury on Thursday awarded a total of $53 million in damages to four mothers claiming Abbott Laboratories' preterm baby formula contributed to their babies' development of a serious and often fatal gut condition, in the first of such claims to go to trial in Illinois.
-
April 09, 2026
Medical Practice Hit With $49M Verdict Over Missed Cancer
A Connecticut jury on Thursday awarded a $49 million verdict against The Westchester Medical Group PC, finding the entity liable after a high-risk patient accused her gynecologist of failing to properly screen her while cervical cancer spread through her chest, abdomen and pelvis.
-
April 09, 2026
Split 4th Circ. Backs West Virginia Schoolchildren Vax Law
A split Fourth Circuit panel struck down an order barring West Virginia from applying a compulsory vaccination law to a student whose parents alleged the law violates her religious rights, ruling the law serves the state's interest in reducing the spread of infectious diseases.
-
April 09, 2026
Merck Beats 295 Zostavax Suits Over Missed Deadlines
A Pennsylvania federal judge has tossed 295 cases against Merck & Co. Inc. in the multidistrict litigation alleging its Zostavax shingles vaccine caused the disease, with the court reasoning that the plaintiffs' inactivity doomed the cases.
-
April 09, 2026
Doctor Who Sued Biotech Co. Over Arrest Wins $58M Verdict
A Georgia jury has handed a $58 million verdict to a retired Stanford University medical school professor who accused a Peach State biotech firm of conspiring to have him criminally charged in a failed bid to avoid paying him millions in product design commissions.
-
April 09, 2026
Pest Co. Can't Eradicate Workers' Suit Over Tobacco Fees
Pest control company Rentokil can't escape a proposed class action alleging it unlawfully charged tobacco users more for health benefits without providing a reasonable way to avoid the fee, with a Pennsylvania federal judge rejecting the company's argument that decade-old regulations were invalid.
-
April 09, 2026
Kirkland-Led Court Square Capital Raises $3.8B
Kirkland & Ellis LLP-advised private equity shop Court Square Capital Partners on Thursday announced that it wrapped its fifth fund with roughly $3.8 billion of capital commitments, marking the firm's largest fundraise to date.
-
April 09, 2026
Philly Injection Site Row Judge Rejects Nonprofit's 'Ploy'
A Pennsylvania federal judge on Thursday called the addition of overdose prevention nonprofit Safehouse's president as a counterclaim plaintiff in the government's suit to stop it from launching a safe-injection site in Philadelphia a "ploy" to add another to the ranks of those claiming the government infringed the group's religious freedom.
-
April 09, 2026
Ex-Pharmacy Director Denies Using Trade Secrets At New Job
A former director at a specialty infusion therapy pharmacy urged a New Jersey federal court to reject her former employer's bid to block her from working for a rival, arguing that her new job does not pose any threat of imminent harm to her former company.
-
April 09, 2026
Feds Cast Calif. Tribe's Opioid Clinic Fight As Money Grab
The federal government says it had justification for rejecting a California tribe's request for an agreement to fund an opioid treatment center, claiming that a challenge over the denial is more about trying to monetize on advantages available to Indigenous nations and less about helping patients.
-
April 09, 2026
Colo. Co. Failed To Prevent Patient Data Leak, Suit Says
A Colorado-based digital health company focused on reversing Type 2 diabetes is facing a proposed class action in federal court alleging it did not protect patients' personal and medical information from a cyberattack in late March that exposed their information to the dark web.
-
April 09, 2026
Elevance Nurses' Federal OT Suit Sent From NC To Va.
A class and collective action accusing insurer Elevance Health of misclassifying its nurses as overtime-exempt has been transferred from North Carolina to Virginia federal court, where the company faces related claims.
-
April 09, 2026
US Again Urges High Court To Back Drug Price Program
The administration of President Donald Trump again urged the Supreme Court not to hear a challenge to the Medicare drug price negotiation program, arguing against a constitutional challenge brought by Boehringer Ingelheim that drug companies aren't forced to accept lower prices because they can choose not to participate.
-
April 08, 2026
Ed. Dept. Says It's Not Required To Fund $1B In Youth Grants
The U.S. Department of Education denied accusations by 16 U.S. states that it is flouting a court order to restore nearly $1 billion in K–12 mental health grants, arguing in a Western District of Washington filing that the order required officials to re-review the grants, not actually provide full funding.
-
April 08, 2026
Va. Hospital Patient Seeks Final Nod For $3.1M Privacy Deal
An Inova Health Care Services patient is urging a Virginia federal judge to grant final approval to a $3.1 million deal to resolve claims the healthcare system unlawfully shared private health information with Meta and Google through online tracking tools, arguing the resolution has received "overwhelming support" from the settlement class.
-
April 08, 2026
Fla. Insurer, Ex-Parent To Pay $135M Over ACA Fraud Scheme
A Florida insurer and its former parent, which is a Delaware-based national partnership of insurance brokers, have agreed to pay $135 million collectively to resolve allegations of a scheme to enroll ineligible consumers into subsidized Affordable Care Act plans and of defrauding the federal government of more than $140 million.
Expert Analysis
-
Series
Playing Tennis Makes Me A Better Lawyer
An instinct to turn pain into purpose meant frequent trips to the tennis court, where learning to move ahead one point at a time was a lesson that also applied to the steep learning curve of patent prosecution law, says Daniel Henry at Marshall Gerstein.
-
Series
Judges On AI: How Judicial Use Informs Guardrails
U.S. Magistrate Judge Maritza Dominguez Braswell at the U.S. District Court for the District of Colorado discusses why having a sense of how generative AI tools behave, where they add value, where they introduce risk and how they are reshaping the practice of law is key for today's judges.
-
Lessons From EdTech Provider's Data Breach Settlements
Education technology company Illuminate Education's recent settlements with three states and the Federal Trade Commission over state privacy law claims following a student data breach are some of the first of their kind, suggesting a shift in enforcement focus to how companies handle student data and highlighting the potential for coordinated enforcement actions, say attorneys at Wilson Sonsini.
-
Justices' Med Mal Ruling May Spur Huge Shift For Litigators
The U.S. Supreme Court’s recent decision in the medical malpractice suit Berk v. Choy, holding that a Florida procedural requirement does not apply to medical malpractice claims filed in federal court, is likely to encourage eligible parties to file claims in federal court, speed the adjudicatory process and create both opportunities and challenges for litigators, says Thomas Kroeger at Colson Hicks.
-
What US Cos. Must Know To Comply With Italy's AI Law
Italy's newly effective artificial intelligence law means U.S. companies operating in Italy or serving Italian customers must now meet EU AI Act obligations as well as Italy-specific requirements, including immediately enforceable criminal penalties, designated national authorities and sector-specific mandates, say attorneys at Portolano Cavallo.
-
Key Sectors, Antitrust Risks In Pricing Algorithm Litigation
Algorithmic pricing lawsuits have proliferated in rental housing, hotels, health insurance and equipment rental industries, and companies should consider emerging risk factors when implementing business strategies this year, say attorneys at Hunton.
-
Ag Bill Wording Presents Existential Threat To Hemp Industry
A proposal in the agriculture appropriations bill for fiscal year 2026, which excludes almost everything synthesized from cannabis from the legal definition of “hemp,” would have catastrophic consequences for thousands of farmers, medical researchers and businesses by banning everything from intoxicating delta-9 THC products to topical CBD creams, says Alissa "Ali" Jubelirer at Benesch.
-
Series
Adapting To Private Practice: 5 Tips From Ex-SEC Unit Chief
My move to private practice has reaffirmed my belief in the value of adaptability, collaboration and strategic thinking — qualities that are essential not only for successful client outcomes, but also for sustained professional satisfaction, says Dabney O’Riordan at Fried Frank.
-
5 Drug Pricing Policy Developments To Watch In 2026
2026 may prove to be a critical year for drug pricing in the U.S., with potential major shifts including several legislative initiatives moving forward after being in the works for years, and more experimentation on the horizon concerning GLP-1s and Section 340B pricing, say attorneys at Manatt.
-
Prisoners' Access To Health Info Should Have No Bars
To safeguard against unnecessary deaths in custody, courts and policymakers should clarify that incarcerated individuals’ constitutional right to medical care also includes access to sufficient information about their medical conditions, lifting current restrictions that can lead to crucial information being withheld, says Jaehyun Oh at Jacob Fuchsberg Law.
-
Navigating The New Wave Of Voluntary Benefit ERISA Suits
Four recent complaints claiming that employees pay unreasonable premiums for voluntary benefit programs contribute to a trend in Employee Retirement Income Security Act class actions targeting employers and benefits consultants over such programs, increasing scrutiny of how the programs are selected, priced and administered, say attorneys at Holland & Knight.
-
Series
Law School's Missed Lessons: How To Start A Law Firm
Launching and sustaining a law firm requires skills most law schools don't teach, but every lawyer should understand a few core principles that can make the leap calculated rather than reckless, says Sam Katz at Athlaw.
-
Justices' Med Mal Ruling May Hurt Federal Anti-SLAPP Suits
The U.S. Supreme Court's recent decision in Berk v. Choy restricts the application of certain state laws in diversity actions in federal court — and while the ruling concerned affidavit requirements in medical malpractice suits, it may also affect the use of anti-SLAPP statutes in federal litigation, says Travis Chance at Brownstein Hyatt.
-
Regulatory Uncertainty Ahead For Organ Transplant System
Pending court cases against a Centers for Medicare and Medicaid Services final rule that introduced a competition-centric model for assessing organ procurement organizations' performance will significantly influence the path forward for such organizations and transplant hospitals, say attorneys at Crowell & Moring.
-
Key False Claims Act Trends From The Last Year
The False Claims Act remains a powerful enforcement tool after some record verdicts and settlements in 2025, and while traditional fraud areas remain a priority, new initiatives are raising questions about its expanding application, says Veronica Nannis at Joseph Greenwald.